TIPE2 and cervical squamous cell carcinoma: Conversely, TNFAIP8L2 predicted a favorable prognosis in CESC (HR = 0.95 (0.92–0.98)), SARC (HR = 0.99 (0.98–1)) and SKCM (HR = 0.98 (0.97–0.99)) (Fig. 3A).